Company: MYSEW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004290
Chunk: 770

Company: Myseum, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 5
Chunk 770
---
 had been developed by our subsidiary.

27

Recent Events

Return of Subsidiary Shares

In January 2025, we returned 3,500,000 shares
of the Subsidiary’s. common stock held by us to the Subsidiary, which shares were cancelled and are no longer outstanding on the
Subsidiary’s stock ledger. Following this transaction, we held 12.5 million shares of the Subsidiary’s common stock, or approximately
34% of its outstanding shares.

January 2025 Offering

On January 8, 2025, we entered into a securities purchase agreement
with certain institutional investors, pursuant to which we sold 1,200,000 shares of our common stock at a purchase price of $4.25 per
share of Common Stock. Proceeds from the offering were approximately $5.1 million, prior to deducting placement agent’s fees and
other offering expenses payable by the Company. The shares of Common Stock were offered by the Company pursuant to its shelf registration
statement on Form S-3 (File No. 333-268058), which was declared effective by the Securities and Exchange Commission on December 6, 2022,
a base prospectus dated December 6, 2022, and a prospectus supplement dated January 8, 2025. The closing of the offering took place on
January 9, 2025. In addition, pursuant to the terms of the offering, the Company issued to The Benchmark Company, LLC, the exclusive placement
agent for the offering, warrants to purchase up to 60,000 shares of the Company’s common stock, at an exercise price equal
to 100.0% of the offering price per share of Common Stock, or $4.25 per share. The Placement Agent Warrant is exercisable during the four-and-a-half
year period commencing six months after the date of the closing of this Offering.

Basis of Presentation

The financial statements contained herein have
been prepared in accordance with accounting principles generally accepted in the United States of America (the “U.S. GAAP”)
and the requirements of the Securities and Exchange Commission.

Critical Estimates

This management’s discussion and analysis
of financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S.
GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported
amounts of assets and liabilities